Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Skin Test Antigen [EPC]
Tuberculin Purified Protein Derivative (PPD) is a sterile, non-infectious diagnostic antigen used in the Mantoux skin test to detect latent tuberculosis infection by identifying delayed-type hypersensitivity reactions in the skin.
Name
Tuberculin Purified Protein Derivative
Raw Name
TUBERCULIN PURIFIED PROTEIN DERIVATIVE
Category
Skin Test Antigen [EPC]
Drug Count
4
Variant Count
13
Last Verified
February 17, 2026
RxCUI
313532, 798408, 798415
UNII
I7L8FKN87J, 3029988O2T, 4WRK2153H3, QNS6W5US1Z
About Tuberculin Purified Protein Derivative
Tuberculin Purified Protein Derivative (PPD) is a sterile, non-infectious diagnostic antigen used in the Mantoux skin test to detect latent tuberculosis infection by identifying delayed-type hypersensitivity reactions in the skin.
Detailed information about Tuberculin Purified Protein Derivative
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Tuberculin Purified Protein Derivative.
Tuberculin Purified Protein Derivative (PPD) is a highly specialized diagnostic antigen used globally as the gold standard for detecting infection with Mycobacterium tuberculosis, the causative agent of tuberculosis (TB). It belongs to a pharmacological class known as skin test antigens. Unlike a vaccine, which is designed to prevent disease, Tuberculin PPD is a diagnostic tool used to identify individuals who have already been exposed to and sensitized by the TB bacteria. The substance itself is a sterile aqueous solution containing a complex mixture of proteins derived from the culture filtrate of Mycobacterium tuberculosis that has been inactivated (killed) and purified to ensure it cannot cause the disease.
Tuberculin PPD was first standardized in the early 20th century, with the current 'PPD-S' (Standard) being established by Florence Seibert in 1939. This standardization was critical for ensuring that the potency of the test remains consistent across different manufacturers and clinical settings. In the United States, the Food and Drug Administration (FDA) has approved commercial preparations such as Tubersol and Aplisol for intradermal (within the skin) administration. These products are typically standardized to 5 Tuberculin Units (TU) per 0.1 mL dose, which is the concentration required for the Mantoux skin test.
Tuberculin PPD works by triggering a localized immune response known as a delayed-type hypersensitivity (DTH) reaction, or a Type IV hypersensitivity reaction. When a small amount of PPD is injected into the intradermal layer of the skin, it acts as an 'alarm' for the immune system. If a person has been previously infected with Mycobacterium tuberculosis, their immune system contains specialized white blood cells called sensitized T-lymphocytes (specifically CD4+ T-cells).
Upon encountering the PPD antigens at the injection site, these sensitized T-cells release chemical messengers called cytokines (such as interferon-gamma and interleukin-2). These cytokines recruit other immune cells, including macrophages and neutrophils, to the site. This influx of cells and the subsequent inflammatory response cause local vasodilation (widening of blood vessels) and edema (fluid buildup), resulting in a hard, raised area called an induration. This process takes time to develop, which is why the test must be read between 48 and 72 hours after administration. If a person has never been exposed to TB, their T-cells will not recognize the PPD, and no significant reaction will occur.
Because Tuberculin PPD is a diagnostic antigen administered intradermally for a localized effect, its pharmacokinetic profile differs significantly from systemic medications like tablets or intravenous drugs.
The primary FDA-approved indication for Tuberculin Purified Protein Derivative is as an aid in the diagnosis of tuberculosis infection (both latent infection and active disease) in adults and children. It is specifically used for:
Tuberculin PPD is available exclusively as an injectable solution for intradermal use. It is typically supplied in multi-dose vials (e.g., 1 mL or 5 mL vials). The standard strength used for the Mantoux test is 5 TU (Tuberculin Units) per 0.1 mL. It is a clear, colorless liquid that must be stored under refrigeration to maintain its potency.
> Important: Only your healthcare provider can determine if Tuberculin Purified Protein Derivative is right for your specific condition. The interpretation of the test results requires professional training and consideration of your individual risk factors.
The standard adult dosage for the Tuberculin Purified Protein Derivative (PPD) skin test is a single intradermal injection of 0.1 mL of the 5 TU (Tuberculin Units) strength. This dose is consistent across all adult populations, regardless of weight or age, as it is designed to provide a standardized amount of antigen to trigger a measurable immune response.
In some specific clinical protocols, such as 'two-step testing' for healthcare workers, a second 0.1 mL dose may be administered 1 to 3 weeks after the initial test if the first test was negative. This is done to 'boost' the immune memory in individuals whose sensitivity to the antigen may have waned over many years, ensuring a more accurate baseline for future testing.
The pediatric dosage for Tuberculin PPD is identical to the adult dosage: 0.1 mL of the 5 TU strength administered intradermally. The American Academy of Pediatrics (AAP) and the Centers for Disease Control and Prevention (CDC) recommend this standardized dose for infants, children, and adolescents. There is no evidence that the dose needs to be adjusted for body surface area or age in the pediatric population, as the skin's immunological capacity to respond to the antigen is sufficiently developed even in early infancy.
No dosage adjustments are required for patients with renal (kidney) impairment. Since the PPD test is a localized diagnostic procedure with minimal systemic absorption, the kidneys are not responsible for clearing the drug in a way that would require dose modification.
No dosage adjustments are necessary for patients with hepatic (liver) impairment. The metabolism of the PPD proteins occurs locally in the skin and through the lymphatic system, rather than through the cytochrome P450 system in the liver.
While the dose remains 0.1 mL, healthcare providers must be aware that elderly patients may exhibit 'anergy' (a lack of immune response) due to a naturally weakened immune system (immunosenescence). This can lead to false-negative results. In these cases, a two-step testing procedure is often recommended to accurately identify latent infection.
Tuberculin PPD must be administered using the Mantoux technique by a trained healthcare professional. It is not for self-administration. The procedure involves:
Because the Tuberculin PPD test is a diagnostic procedure rather than a daily medication, a 'missed dose' refers to a missed appointment for reading the test. The test must be read by a healthcare professional 48 to 72 hours after the injection. If you miss this window, the results are considered invalid. You will likely need to wait at least one week before the test can be repeated to avoid interference from the previous injection.
Systemic overdose of Tuberculin PPD is extremely rare because it is administered in such small, controlled volumes (0.1 mL). However, an accidental subcutaneous (deeper) injection or an excessive dose could lead to a severe local reaction, including extensive swelling, pain, or even tissue necrosis (skin death) at the injection site. There is no specific 'antidote' for PPD; treatment focuses on managing the local inflammation and monitoring for rare systemic allergic reactions.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or attempt to interpret the skin reaction yourself without medical guidance.
The most common side effects of Tuberculin Purified Protein Derivative (PPD) are localized to the site of the injection. These are typically mild and represent the body's natural response to the antigen.
In some individuals, particularly those who are highly sensitive to the tuberculin antigen, the local reaction may be more pronounced.
Rarely, the PPD test can cause more significant or systemic issues.
While Tuberculin PPD does not contain live bacteria, it can trigger severe allergic reactions in rare cases.
> Warning: Stop taking Tuberculin Purified Protein Derivative and call your doctor immediately if you experience any of these.
There are generally no long-term systemic side effects associated with a single PPD test. The most significant long-term effect is the potential for a permanent scar at the injection site if a severe local necrotic reaction occurred. Additionally, once a person has a documented positive PPD test, they will likely remain positive for life; therefore, repeated skin testing is usually not recommended, and future screenings should be done via blood tests (IGRAs) or chest X-rays.
There are currently no FDA Black Box Warnings for Tuberculin Purified Protein Derivative. It is considered a safe diagnostic tool when used according to standardized protocols. However, it is contraindicated in individuals who have had a previous severe necrotic reaction to a TB skin test.
Report any unusual symptoms to your healthcare provider. If you notice a reaction that is larger than 15mm or involves blistering, ensure you do not cover it with a tight bandage, as this can worsen the skin breakdown.
Tuberculin Purified Protein Derivative (PPD) is a diagnostic tool and must be handled with care. It is vital to understand that a positive PPD test does not necessarily mean you have active, contagious tuberculosis; it means you have been infected with the bacteria at some point. Conversely, a negative test does not 100% rule out TB, especially in those with severely weakened immune systems. The timing of the reading (48-72 hours) is critical; reading the test too early or too late will result in an inaccurate diagnosis, potentially leading to unnecessary treatment or a missed infection.
No FDA black box warnings for Tuberculin Purified Protein Derivative. It has a long history of safe use in public health screening programs worldwide.
There are no specific laboratory tests required before receiving a PPD test. However, the 'monitoring' involves the mandatory physical examination of the injection site by a healthcare professional 48 to 72 hours after administration. If the test is positive, subsequent monitoring will include:
Tuberculin PPD does not affect the central nervous system. It does not cause drowsiness or impair coordination. You may drive and operate machinery immediately after the test, provided you do not feel lightheaded from the injection process itself.
There is no direct interaction between alcohol and the Tuberculin PPD antigen. However, chronic heavy alcohol use can weaken the immune system, potentially leading to a diminished skin test response (false negative). If a patient is diagnosed with TB and starts treatment, alcohol must be strictly avoided as it significantly increases the risk of liver damage from TB medications.
As a single-dose diagnostic test, 'discontinuation' is not applicable. However, if a patient experiences an immediate allergic reaction during the injection, the procedure should be stopped immediately. There is no withdrawal syndrome associated with PPD.
> Important: Discuss all your medical conditions with your healthcare provider before starting Tuberculin Purified Protein Derivative, especially if you have a history of severe skin reactions or are taking medications that affect your immune system.
There are no drugs that are strictly contraindicated in the sense of causing a lethal chemical reaction with PPD. However, certain combinations are avoided because they make the test result completely uninterpretable.
These interactions may not prevent the test from being performed, but they require careful consideration when interpreting the results.
There are no known food interactions with Tuberculin Purified Protein Derivative. You do not need to fast or avoid specific foods (like grapefruit or dairy) before or after the skin test. Your diet will not affect the localized immune response in the skin.
While most herbal supplements do not have a documented interaction with PPD, any supplement with potent 'immune-boosting' or 'immune-suppressing' claims should be mentioned to your doctor. For example, very high doses of certain antioxidants or anti-inflammatory herbs could theoretically modulate the skin's inflammatory response, though clinical data on this is lacking.
Tuberculin PPD does not interfere with standard blood chemistry, hematology, or urinalysis tests. However, it may interfere with other skin tests. If you are receiving multiple skin tests (e.g., for allergies or other infections), they should be spaced out or performed on different areas of the body to avoid 'cross-talk' between the immune responses.
For each major interaction, the mechanism is usually pharmacodynamic—meaning the interacting substance affects how the body responds to the PPD antigen, rather than changing the concentration of the PPD itself. The clinical consequence is almost always a false-negative result, which is dangerous because it leaves a TB infection undiagnosed. The management strategy is to delay the PPD test until the interfering factor (like a viral infection or a course of steroids) has resolved, or to use a different diagnostic method like the IGRA blood test.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially if you have recently received any vaccinations.
There are specific circumstances where Tuberculin Purified Protein Derivative (PPD) must NEVER be used because the risk of a severe reaction outweighs any diagnostic benefit.
In these situations, the healthcare provider will perform a risk-benefit analysis and may choose an alternative testing method.
There is a potential for cross-sensitivity between different brands of Tuberculin PPD (e.g., switching between Tubersol and Aplisol). While they are standardized to the same potency, the inactive ingredients (preservatives/stabilizers) may differ slightly. Additionally, individuals who react to the BCG vaccine will often show a cross-reactive positive result on the PPD test, although this is an immunological cross-reactivity rather than a classic allergic cross-sensitivity.
> Important: Your healthcare provider will evaluate your complete medical history, including previous TB test results and vaccination history, before prescribing Tuberculin Purified Protein Derivative.
Tuberculin Purified Protein Derivative is considered safe for use during pregnancy. According to the CDC and the American College of Obstetricians and Gynecologists (ACOG), pregnancy does not diminish the skin's sensitivity to PPD, nor does the test pose a risk to the developing fetus. There is no evidence of teratogenicity (birth defects) because the PPD proteins do not enter the systemic circulation in significant amounts. Screening pregnant women for TB is particularly important because active TB during pregnancy can lead to poor maternal and neonatal outcomes, including low birth weight and congenital TB.
It is safe to receive a PPD skin test while breastfeeding. The PPD proteins are not absorbed into the bloodstream in quantities that would allow them to pass into breast milk. There is no risk to the nursing infant, and breastfeeding does not need to be interrupted. The diagnostic benefits of identifying and treating TB in a breastfeeding mother are critical for protecting the infant from exposure to active disease.
Tuberculin PPD is approved and widely used in the pediatric population, including infants. It is the standard method for TB screening in children. Healthcare providers must be careful to ensure the injection is truly intradermal, as children have thinner skin. In very young infants (under 6 months), the immune system may be slightly less responsive, but the 5 TU dose remains the standard. The test is NOT used to diagnose TB in children who have recently received certain live vaccines until the appropriate waiting period has passed.
In elderly patients, the PPD test must be interpreted with caution. Due to 'immunosenescence' (the gradual weakening of the immune system with age), an elderly person with a latent TB infection may have a negative skin test. This is why the 'two-step' test is frequently used in nursing homes and long-term care facilities. If the first test is negative, a second test is given 1-3 weeks later to 'recall' the immune response. If the second test is positive, it indicates a long-standing latent infection rather than a new one.
Patients with end-stage renal disease (ESRD) or those on hemodialysis often have suppressed cellular immunity. This can lead to a high rate of false-negative PPD results. While the dose does not change, a negative result in a patient with significant renal impairment cannot reliably rule out TB infection. In this population, blood tests (IGRAs) are often preferred.
There are no special considerations for PPD testing in patients with liver disease. The test is safe and the dosage remains the same. However, if the test is positive, the choice of subsequent TB treatment will be heavily influenced by the degree of hepatic impairment, as many TB drugs are hepatotoxic.
> Important: Special populations require individualized medical assessment to ensure that the test results are interpreted accurately within the context of their overall health.
Tuberculin Purified Protein Derivative (PPD) functions as a diagnostic provocateur of the cell-mediated immune system. The molecular mechanism involves the recognition of mycobacterial antigens by sensitized T-lymphocytes. Specifically, the PPD contains proteins like ESAT-6 and CFP-10 (though in a crude mixture compared to modern blood tests). When these proteins are introduced into the dermis, they are taken up by Antigen-Presenting Cells (APCs), such as dendritic cells. These APCs present the PPD fragments on their surface via Major Histocompatibility Complex (MHC) class II molecules. Sensitized CD4+ T-helper cells (Th1 cells) recognize these complexes and secrete pro-inflammatory cytokines, primarily Interferon-gamma (IFN-γ) and Tumor Necrosis Factor-alpha (TNF-α). This triggers a cascade that results in the characteristic firm swelling (induration) at the site.
The pharmacodynamics of PPD are characterized by the 'time-to-reaction.' The onset of the visible immune response typically begins 5 to 6 hours after injection, peaks between 48 and 72 hours, and slowly subsides over several days or weeks. The relationship between the dose (5 TU) and the response (diameter of induration) is standardized; however, the magnitude of the response is governed by the host's 'immunological memory' rather than the drug's concentration alone. Tolerance does not develop in the traditional sense, but repeated frequent testing can lead to a 'booster effect.'
| Parameter | Value |
|---|---|
| Bioavailability | Negligible (Intradermal localization) |
| Protein Binding | N/A (Local tissue interaction) |
| Half-life | ~24-48 hours (Local degradation) |
| Tmax | 48-72 hours (Peak of skin reaction) |
| Metabolism | Local tissue proteases and macrophages |
| Excretion | Lymphatic clearance of fragments |
Tuberculin PPD is not a single molecule but a complex mixture of water-soluble protein fractions. It is derived from Mycobacterium tuberculosis (Strain DT, PN, or C) grown in a synthetic medium. The culture is heat-killed, filtered, and the proteins are precipitated (usually with trichloroacetic acid or ammonium sulfate) and then re-dissolved. The final solution contains Phenol (0.28%) as a preservative and Polysorbate 80 (0.0005%) as a stabilizer to prevent the proteins from sticking to the glass vial or plastic syringe.
Tuberculin PPD is classified as a Skin Test Antigen. It is distinct from vaccines (which induce immunity) and from in-vitro diagnostics (like blood tests). It is the primary agent used in the Mantoux test, which remains the most widely used screening tool for tuberculosis globally due to its low cost and lack of requirement for a laboratory.
Medications containing this ingredient
Common questions about Tuberculin Purified Protein Derivative
Tuberculin Purified Protein Derivative (PPD) is a diagnostic tool used to determine if a person has been infected with the bacteria that cause tuberculosis (TB). It is administered as a skin test, known as the Mantoux test, where a small amount of the liquid is injected just under the surface of the skin on the forearm. If you have been exposed to TB in the past, your immune system will recognize the PPD and create a firm, raised bump at the injection site. This test is a standard part of screening for healthcare workers, people traveling to high-risk areas, and those who have been in contact with someone with active TB. It helps doctors identify 'latent' TB, which is an infection that isn't making you sick yet but could become active later. Only a trained healthcare professional can administer and read this test.
The most common side effects of a PPD skin test are localized to the area where the injection was given. Most people experience mild redness, swelling, or itching at the site, which is a normal part of the body's reaction to the test. Some individuals may feel a slight stinging or burning sensation during the injection itself. In people who have a strong positive reaction, the area may become quite hard, sore, and may even develop a small blister. These local symptoms usually resolve on their own within a few days. Systemic side effects like fever or body aches are extremely rare. If you experience severe pain, extensive bruising, or signs of an allergic reaction like hives, you should contact your doctor.
There is no known direct interaction between alcohol consumption and the Tuberculin PPD skin test. Drinking alcohol will not change the chemical makeup of the PPD or cause a dangerous reaction with the injection. However, it is generally advised to avoid excessive alcohol because it can affect your immune system's ability to respond accurately to the test, potentially leading to a less clear result. Furthermore, if your PPD test comes back positive and you are diagnosed with tuberculosis, you will likely be started on medications that are very hard on the liver. In that case, your doctor will strictly advise you to avoid alcohol to prevent severe liver damage. For the 48 to 72 hours while waiting for your test to be read, moderate alcohol use is typically not an issue.
Yes, Tuberculin Purified Protein Derivative is considered safe and is recommended for pregnant women who are at high risk for tuberculosis. The test involves a very small amount of protein injected into the skin, and it does not travel through the bloodstream to the developing baby. According to the CDC, the PPD skin test is both valid and safe throughout all trimesters of pregnancy. Identifying a TB infection is actually very important for pregnant women, as active TB can cause serious complications for both the mother and the infant. If you are pregnant, you should inform your healthcare provider, but you should not be afraid to take the test if it is medically necessary. There is no evidence that the test causes birth defects or pregnancy loss.
The Tuberculin PPD test does not provide immediate results; it relies on a 'delayed' immune response. After the injection is given, you must wait between 48 and 72 hours for the reaction to fully develop. During this time, your immune system's T-cells are traveling to the injection site to 'inspect' the PPD proteins. If they recognize the proteins from a previous infection, they will cause the skin to become hard and raised. If you check the site after only 24 hours, the reaction may not be fully formed yet. Conversely, if you wait longer than 72 hours, the reaction may begin to fade, leading to an inaccurate reading. You must return to your healthcare provider's office within that specific 48-to-72-hour window to have the test officially read.
The concept of 'stopping' the medication does not apply to Tuberculin PPD because it is not a chronic treatment. It is a single-dose diagnostic injection given once (or twice in a two-step protocol). Once the 0.1 mL dose is injected into your skin, it cannot be removed, and it will naturally be broken down by your body over the next several days. There are no withdrawal symptoms or long-term effects from the substance itself. If you decide you do not want to complete the test after the injection has been given, the only 'discontinuation' would be failing to return to the doctor to have the result read. However, this is not recommended as it leaves your TB status unknown, which could be a risk to your health and the health of others.
Since Tuberculin PPD is a one-time diagnostic test, a 'missed dose' usually means you missed your appointment to have the skin reaction read by a professional. If you do not have the test read within the required 48-to-72-hour window, the result is considered invalid and cannot be used for medical or employment purposes. In this situation, you should contact your healthcare provider to schedule a new test. Usually, you will need to wait at least one week before the test can be repeated to ensure the second injection isn't affected by the first one. It is very important to make sure you can return for the follow-up reading before you agree to have the initial injection.
No, Tuberculin Purified Protein Derivative does not cause weight gain. It is a diagnostic antigen used in a very tiny amount (0.1 mL) for a localized skin test. It does not contain hormones, steroids, or any ingredients that affect your metabolism, appetite, or fat storage. Any changes in weight you might be experiencing would be unrelated to the PPD test itself. However, it is worth noting that 'unexplained weight loss' is a common symptom of active tuberculosis. If you are being tested for TB because you have been losing weight without trying, a positive PPD test might help your doctor find the underlying cause of that weight loss so you can begin proper treatment.
Tuberculin PPD can be administered while you are taking most medications, but some drugs can interfere with the accuracy of the test. Specifically, medications that suppress your immune system—such as high-dose steroids (like prednisone), chemotherapy, or biologics used for autoimmune diseases—can cause a 'false negative' result. This means the test might look negative even if you actually have a TB infection. Also, live virus vaccines (like the MMR or chickenpox vaccine) should be given either on the same day as the PPD test or you should wait 4 to 6 weeks after the vaccine before getting the skin test. Always provide your healthcare provider with a full list of your current medications and recent vaccinations before getting the test.
Tuberculin Purified Protein Derivative is available under brand names like Tubersol and Aplisol, but these are essentially standardized versions of the same biological product. In the world of biologics and diagnostic antigens, the term 'generic' is slightly different than it is for chemical pills like ibuprofen. However, both Tubersol and Aplisol are considered equivalent and are used interchangeably in most clinical settings. There is no 'cheaper' generic version in the way people often think of generic drugs, but the cost of the PPD test is generally very low and often covered by insurance or provided for free by public health departments because it is a vital tool for controlling the spread of tuberculosis.